ULTIVUE
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 24 Jan 2025)
What this means for you
Registered since 04 Sept 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86645457
- Registration number
- 5556072
- Mark type
- Stylized text
- Filed
- 29 May 2015
- Published for opposition
- 17 Nov 2015
- Registered
- 04 Sept 2018
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Biochemical reagents for fluorescent bio-imaging for medical purposes; Chemical reagents for the detection and visualization of nucleic acids, proteins, and other biomolecules for medical purposes; Chemical reagents for use in the field of microscopic fluorescent imaging for medical purposes
- Class 042 — Scientific and technological services: Design and development of chemical reagents and biochemical assays; Medical and scientific research and clinical diagnostics in the field of microscopic fluorescent imaging
Owner
- Ultivue, Inc., Cambridge, MA, US
- Ultivue, Inc., Cambridge, MA, US
- Ultivue, Inc., Chicago, IL, US
Prosecution history
- 24 Jan 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 24 Jan 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 24 Jan 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Sept 2024 — TEAS SECTION 8 & 15 RECEIVED
- 04 Sept 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 04 Sept 2018 — REGISTERED-PRINCIPAL REGISTER
- 31 Jul 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Jul 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Jul 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Jul 2018 — USE AMENDMENT FILED
- 26 Jul 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Jul 2018 — TEAS STATEMENT OF USE RECEIVED
- 03 Jul 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Jan 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jan 2018 — SOU EXTENSION 4 GRANTED